+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Next-Generation Oncology Devices & Solutions Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5925142
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The next-generation oncology devices and solutions market is experiencing transformative change, driven by advances in technology and shifts in clinical and regulatory landscapes. Senior decision-makers need reliable market intelligence to guide technology procurement, operational planning, and strategy in a dynamic oncology ecosystem.

Market Snapshot: Oncology Devices & Solutions

The global next-generation oncology devices and solutions market has grown from USD 23.05 billion in 2025 to USD 28.02 billion in 2026, and is projected to reach USD 91.18 billion by 2032 at a CAGR of 21.70%. This growth is supported by healthcare systems seeking advanced diagnostics, integrated therapeutic platforms, and streamlined clinical workflows. The market’s trajectory reflects a pressing demand for efficient, data-driven, and connected solutions tailored to evolving oncology needs.

Scope & Segmentation of the Oncology Device Ecosystem

This report offers a comprehensive segmentation to enable alignment with high-growth areas across the oncology technology landscape:

  • Device Types: Encompasses diagnostic devices such as fluorescence in situ hybridization and immunohistochemistry, next generation sequencing (NGS) platforms with applications like exome sequencing, targeted panels, and whole genome sequencing, as well as polymerase chain reaction (PCR) devices including digital and quantitative PCR. Imaging devices consist of computed tomography (cone beam and multi-slice), high and ultra-high field magnetic resonance imaging, PET/CT and PET/MRI, ultrasound (2D and 3D/4D), and X-ray systems. Monitoring solutions feature biosensors and wearables, while interventional devices include cryosurgery, laparoscopic, and robotic surgery technologies. Therapeutic devices range from advanced drug delivery and radiation therapy equipment such as brachytherapy and proton therapy, to linear accelerators.
  • Technology Platforms: Features advancements in artificial intelligence (data analytics, deep learning, machine learning), bioinformatics for NGS and proteomics, as well as digital pathology, nanotechnology (nanocarriers and nanodiagnostics), and robotics for diagnostic and surgical use.
  • Cancer Indications: Covers devices and solutions addressing breast, colorectal, lung, and prostate cancers, which require specific workflow integration and protocols.
  • End Users: Includes ambulatory centers, diagnostic laboratories, hospitals, and research institutes, each with unique technology adoption cycles and procurement considerations.
  • Geographic Regions: Spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, incorporating analysis of regulatory differences, infrastructure development, and regional payer dynamics.

Key Takeaways for Senior Decision-Makers

  • Technological convergence is enhancing connected care pathways by integrating diagnostics, imaging, robotics, and digital health workflows, supporting more informed clinical decision-making for oncology teams.
  • Device platforms are moving from standalone systems toward interoperability, which enables real-time patient monitoring and improved coordination across the continuum of cancer care.
  • Supply chain resilience is a key market dynamic, prompting organizations to diversify supplier bases, consider nearshoring, and adopt modular device designs to minimize risk exposure.
  • Regulatory and reimbursement trends emphasize real-world evidence and lifecycle data, motivating investment in robust data collection and post-market monitoring structures.
  • Strategic partnerships between device manufacturers, software developers, and research bodies are facilitating faster clinical validation and innovation in service delivery models.

Tariff Impact: Navigating Trade Policy and Supply Chain Risk

The current tariff and trade environment has introduced additional complexity for manufacturers and providers relying on global supply chains for oncology devices. Heightened tariffs on precision optics and semiconductor components have necessitated a re-evaluation of existing supplier relationships. Sector leaders are responding by prioritizing operational scenario planning, leveraging modular device architectures, and increasing collaboration with contract manufacturers. These strategies help build supply chain resilience and ensure continued access to essential oncology technologies amidst shifting trade policies.

Methodology & Data Sources

This report is based on primary interviews with clinicians, procurement managers, and regulatory authorities, combined with thorough reviews of technical documents, regulatory guidance, and peer-reviewed literature. Analytical rigor, triangulation of segment data, and scenario validation ensure insights with practical relevance for strategy and procurement.

Why This Report Matters

  • Enables senior teams to pinpoint growth opportunities where device innovation, technology platforms, and clinical needs intersect.
  • Supports risk and supply chain planning by providing actionable insights into procurement and regulatory trends impacting oncology technologies.
  • Acts as a ready reference for aligning product development and commercialization strategies to evolving stakeholder expectations and varying regional requirements.

Conclusion

The integration of sophisticated diagnostics, therapies, and digital solutions is redefining oncology care delivery. Organizations that proactively align with clinical, regulatory, and operational shifts will solidify their position and drive meaningful outcomes in a rapidly evolving market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Next-Generation Oncology Devices & Solutions Market, by Device Type
8.1. Diagnostic Devices
8.1.1. Fluorescence In Situ Hybridization
8.1.2. Immunohistochemistry
8.1.3. Next Generation Sequencing
8.1.3.1. Exome Sequencing
8.1.3.2. Targeted Panels
8.1.3.3. Whole Genome Sequencing
8.1.4. Polymerase Chain Reaction
8.1.4.1. Digital PCR
8.1.4.2. Quantitative PCR
8.2. Imaging Devices
8.2.1. Computed Tomography
8.2.1.1. Cone Beam CT
8.2.1.2. Multi-Slice CT
8.2.2. Magnetic Resonance Imaging
8.2.2.1. 1.5T Imaging
8.2.2.2. 3T Imaging
8.2.3. Positron Emission Tomography
8.2.3.1. PET/CT Hybrid
8.2.3.2. PET/MRI Hybrid
8.2.4. Ultrasound Imaging
8.2.4.1. 2D Imaging
8.2.4.2. 3D/4D Imaging
8.2.5. X-Ray Imaging
8.2.5.1. Computed Radiography
8.2.5.2. Digital Radiography
8.3. Monitoring Devices
8.3.1. Biosensors
8.3.2. Wearable Devices
8.4. Surgical Devices
8.4.1. Cryosurgery
8.4.2. Laparoscopic Surgery
8.4.3. Robotic Surgery
8.5. Therapeutic Devices
8.5.1. Drug Delivery Devices
8.5.2. Radiation Therapy Devices
8.5.2.1. Brachytherapy Systems
8.5.2.2. Linear Accelerators
8.5.2.3. Proton Therapy Systems
9. Next-Generation Oncology Devices & Solutions Market, by Technology
9.1. Artificial Intelligence
9.1.1. Data Analytics
9.1.2. Deep Learning
9.1.3. Machine Learning
9.2. Bioinformatics
9.2.1. NGS Data Analysis
9.2.2. Proteomics Data Analysis
9.3. Digital Pathology
9.3.1. Image Analysis Software
9.3.2. Whole Slide Imaging
9.4. Nanotechnology
9.4.1. Nanocarriers
9.4.2. Nanodiagnostics
9.5. Robotics
9.5.1. Biopsy Robotics
9.5.2. Surgical Robotics
10. Next-Generation Oncology Devices & Solutions Market, by Cancer Type
10.1. Breast Cancer
10.2. Colorectal Cancer
10.3. Lung Cancer
10.4. Prostate Cancer
11. Next-Generation Oncology Devices & Solutions Market, by End User
11.1. Ambulatory Care Centers
11.2. Diagnostic Laboratories
11.3. Hospitals
11.4. Research Institutes
12. Next-Generation Oncology Devices & Solutions Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Next-Generation Oncology Devices & Solutions Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Next-Generation Oncology Devices & Solutions Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Next-Generation Oncology Devices & Solutions Market
16. China Next-Generation Oncology Devices & Solutions Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Agilent Technologies, Inc.
17.7. Bio-Rad Laboratories, Inc.
17.8. Brainlab
17.9. Danaher Corporation
17.10. Exact Sciences Corp.
17.11. F. Hoffmann-La Roche Ltd.
17.12. GE HealthCare Technologies, Inc.
17.13. Guardant Health Inc.
17.14. Hologic, Inc.
17.15. Illumina, Inc.
17.16. Johnson & Johnson Services Inc.
17.17. Merck & Co., Inc.
17.18. Myriad Genetics, Inc.
17.19. NanoString Technologies, Inc.
17.20. Natera, Inc.
17.21. NeoGenomics, Inc.
17.22. Novartis AG
17.23. Paige.AI, Inc.
17.24. PerkinElmer, Inc.
17.25. QIAGEN N.V.
17.26. Quest Diagnostics Incorporated
17.27. Royal Philips
17.28. Siemens AG
17.29. Sysmex Corporation
17.30. Takara Bio USA, Inc.
17.31. Thermo Fisher Scientific Inc.
17.32. Veracyte, Inc.
List of Figures
FIGURE 1. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY TARGETED PANELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY TARGETED PANELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY TARGETED PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY QUANTITATIVE PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY QUANTITATIVE PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMAGING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMAGING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMAGING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MULTI-SLICE CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MULTI-SLICE CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MULTI-SLICE CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 1.5T IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 1.5T IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 1.5T IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 3T IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 3T IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 3T IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PET/CT HYBRID, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PET/CT HYBRID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PET/CT HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PET/MRI HYBRID, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PET/MRI HYBRID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PET/MRI HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 3D/4D IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 3D/4D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY 3D/4D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY X-RAY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY X-RAY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY X-RAY IMAGING, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOSENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOSENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CRYOSURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CRYOSURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CRYOSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ROBOTIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ROBOTIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ROBOTIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DRUG DELIVERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DRUG DELIVERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY RADIATION THERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY RADIATION THERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY RADIATION THERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY RADIATION THERAPY DEVICES, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BRACHYTHERAPY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BRACHYTHERAPY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BRACHYTHERAPY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LINEAR ACCELERATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LINEAR ACCELERATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LINEAR ACCELERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PROTON THERAPY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PROTON THERAPY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PROTON THERAPY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DATA ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DATA ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NGS DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NGS DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NGS DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PROTEOMICS DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PROTEOMICS DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PROTEOMICS DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY WHOLE SLIDE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY WHOLE SLIDE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY WHOLE SLIDE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANOCARRIERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANOCARRIERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANOCARRIERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANODIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANODIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANODIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ROBOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ROBOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ROBOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ROBOTICS, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOPSY ROBOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOPSY ROBOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOPSY ROBOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SURGICAL ROBOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SURGICAL ROBOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SURGICAL ROBOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 218. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 219. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 220. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 221. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 222. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 223. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 224. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY X-RAY IMAGING, 2018-2032 (USD MILLION)
TABLE 225. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 226. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 227. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 228. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY RADIATION THERAPY DEVICES, 2018-2032 (USD MILLION)
TABLE 229. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 230. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2032 (USD MILLION)
TABLE 231. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 232. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2032 (USD MILLION)
TABLE 233. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NANOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ROBOTICS, 2018-2032 (USD MILLION)
TABLE 235. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 236. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY X-RAY IMAGING, 2018-2032 (USD MILLION)
TABLE 248. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 249. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 250. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 251. NORTH AMERICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY RADIATION THERAPY DEVICES, 20

Companies Mentioned

The key companies profiled in this Next-Generation Oncology Devices & Solutions market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Brainlab
  • Danaher Corporation
  • Exact Sciences Corp.
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies, Inc.
  • Guardant Health Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Johnson & Johnson Services Inc.
  • Merck & Co., Inc.
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • Natera, Inc.
  • NeoGenomics, Inc.
  • Novartis AG
  • Paige.AI, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Royal Philips
  • Siemens AG
  • Sysmex Corporation
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.

Table Information